XML 38 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Millions
Total
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
RETAINED EARNINGS
ACCUMULATED OTHER COMPREHENSIVE LOSS
TREASURY SHARES
NON-CONTROLLING INTERESTS
Balance, beginning of period at Dec. 31, 2023   $ 561 $ 1,242 $ 22,759 $ (5,295) $ (7,076) $ 179
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (205)        
Issuance of shares under stock compensation plans and employee stock purchase plans     75     178  
Net income $ 1,424     1,400     24
Dividend equivalents declared       (5)      
Dividends declared       (698)      
Other comprehensive income (loss), net of tax (214)       (214)    
Purchase of treasury shares (300)         (300)  
Distributions and other changes             (3)
Balance, end of period at Mar. 31, 2024 $ 12,622   1,112 23,456 (5,509) (7,198) 200
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividend per share (in dollars per share) $ 1.42            
Balance, beginning of period at Dec. 31, 2024 $ 13,535 $ 561 1,370 25,306 (6,240) (7,655) 193
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accrued stock compensation costs     (226)        
Issuance of shares under stock compensation plans and employee stock purchase plans     109     221  
Net income 1,412     1,381     31
Dividend equivalents declared       (5)      
Dividends declared       (801)      
Other comprehensive income (loss), net of tax 344       344    
Purchase of treasury shares (300)         (300)  
Distributions and other changes             (21)
Balance, end of period at Mar. 31, 2025 $ 14,268   $ 1,253 $ 25,881 $ (5,896) $ (7,734) $ 203
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Dividend per share (in dollars per share) $ 1.63